From black and white to shades of gray: race and renin-angiotensin system blockade

J Am Coll Cardiol. 2008 May 13;51(19):1872-3. doi: 10.1016/j.jacc.2008.01.039.
No abstract available

Publication types

  • Editorial
  • Research Support, N.I.H., Extramural
  • Comment

MeSH terms

  • Angiotensin II Type 1 Receptor Blockers / therapeutic use
  • Angiotensin-Converting Enzyme Inhibitors / therapeutic use
  • Antihypertensive Agents / therapeutic use*
  • Black or African American*
  • Captopril / therapeutic use
  • Heart Failure / complications*
  • Heart Failure / drug therapy
  • Heart Failure / mortality
  • Humans
  • Myocardial Infarction / complications*
  • Myocardial Infarction / drug therapy
  • Myocardial Infarction / mortality
  • Renin-Angiotensin System / drug effects*
  • Tetrazoles / therapeutic use
  • United States
  • Valine / analogs & derivatives
  • Valine / therapeutic use
  • Valsartan
  • Ventricular Dysfunction, Left / complications*
  • Ventricular Dysfunction, Left / drug therapy
  • Ventricular Dysfunction, Left / mortality
  • White People*

Substances

  • Angiotensin II Type 1 Receptor Blockers
  • Angiotensin-Converting Enzyme Inhibitors
  • Antihypertensive Agents
  • Tetrazoles
  • Valsartan
  • Captopril
  • Valine